A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
- PMID: 32183941
- PMCID: PMC7142693
- DOI: 10.1016/j.chom.2020.03.002
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
Abstract
Effective countermeasures against the recent emergence and rapid expansion of the 2019 novel coronavirus (SARS-CoV-2) require the development of data and tools to understand and monitor its spread and immune responses to it. However, little information is available about the targets of immune responses to SARS-CoV-2. We used the Immune Epitope Database and Analysis Resource (IEDB) to catalog available data related to other coronaviruses. This includes SARS-CoV, which has high sequence similarity to SARS-CoV-2 and is the best-characterized coronavirus in terms of epitope responses. We identified multiple specific regions in SARS-CoV-2 that have high homology to the SARS-CoV virus. Parallel bioinformatic predictions identified a priori potential B and T cell epitopes for SARS-CoV-2. The independent identification of the same regions using two approaches reflects the high probability that these regions are promising targets for immune recognition of SARS-CoV-2. These predictions can facilitate effective vaccine design against this virus of high priority.
Keywords: B cell epitope; COVID-19; SARS-CoV; SARS-CoV-2; T cell epitope; coronavirus; infectious disease; sequence conservation.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests La Jolla Institute for Immunology (LJI) has filed a patent application regarding this manuscript.
Figures
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7142693/bin/fx1_lrg.gif)
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7142693/bin/gr1_lrg.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7142693/bin/gr2_lrg.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7142693/bin/gr3_lrg.gif)
Update of
-
Candidate Targets for Immune Responses to 2019-Novel Coronavirus (nCoV): Sequence Homology- and Bioinformatic-Based Predictions.SSRN [Preprint]. 2020 Feb 25:3541361. doi: 10.2139/ssrn.3541361. SSRN. 2020. Update in: Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2. doi: 10.1016/j.chom.2020.03.002. PMID: 32714104 Free PMC article. Updated. Preprint.
Similar articles
-
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.Front Immunol. 2020 Sep 3;11:2008. doi: 10.3389/fimmu.2020.02008. eCollection 2020. Front Immunol. 2020. PMID: 33013857 Free PMC article. Review.
-
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.Sci Rep. 2020 Aug 25;10(1):14179. doi: 10.1038/s41598-020-70864-8. Sci Rep. 2020. PMID: 32843695 Free PMC article.
-
Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.Infect Dis Poverty. 2020 Jul 10;9(1):88. doi: 10.1186/s40249-020-00713-3. Infect Dis Poverty. 2020. PMID: 32741372 Free PMC article.
-
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.Allergy. 2020 Jul;75(7):1564-1581. doi: 10.1111/all.14364. Allergy. 2020. PMID: 32396996 Free PMC article. Review.
-
Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.J Med Virol. 2020 Jun;92(6):618-631. doi: 10.1002/jmv.25736. Epub 2020 Mar 5. J Med Virol. 2020. PMID: 32108359 Free PMC article.
Cited by
-
SARS-CoV-2 envelope protein regulates innate immune tolerance.iScience. 2024 May 15;27(6):109975. doi: 10.1016/j.isci.2024.109975. eCollection 2024 Jun 21. iScience. 2024. PMID: 38827398 Free PMC article.
-
COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation.Viruses. 2024 May 11;16(5):763. doi: 10.3390/v16050763. Viruses. 2024. PMID: 38793644 Free PMC article.
-
COVID-19 Variants and Vaccine Development.Viruses. 2024 May 10;16(5):757. doi: 10.3390/v16050757. Viruses. 2024. PMID: 38793638 Free PMC article. Review.
-
FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells.Front Immunol. 2024 May 8;15:1386160. doi: 10.3389/fimmu.2024.1386160. eCollection 2024. Front Immunol. 2024. PMID: 38779658 Free PMC article.
-
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins.Vaccines (Basel). 2024 Apr 2;12(4):379. doi: 10.3390/vaccines12040379. Vaccines (Basel). 2024. PMID: 38675761 Free PMC article.
References
-
- Cheung Y.K., Cheng S.C., Sin F.W., Chan K.T., Xie Y. Investigation of immunogenic T-cell epitopes in SARS virus nucleocapsid protein and their role in the prevention and treatment of SARS infection. Hong Kong Med. J. 2008;14(Suppl 4):27–30. - PubMed
-
- da Silva Antunes R., Paul S., Sidney J., Weiskopf D., Dan J.M., Phillips E., Mallal S., Crotty S., Sette A., Lindestam Arlehamn C.S. Correction: Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses. PLoS One. 2018;13:e0193382. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous